NEJM publishes ALTUVOCT® phase 3 XTEND-Kids results highlighting treatment potential for children with severe haemophilia A
XTEND-Kids is the first assessment of once-weekly ALTUVOCT® prophylaxis in previously treated childrenResults indicate highly effective bleed protection in children under 12 years of age with severe haemophilia A STOCKHOLM, July 18, 2024 /PRNewswire/ — Sobi® today announced the publication o
Harvest the Future: BIOFACH INDIA 2024 – Showcasing India’s Finest Organic, Natural and Millet Produce, igniting Trends and Innovations
The industry hub is all set to bring together the organic, natural, and millets industry from August 3 – 5, 2024 at IEML, Greater Noida, Delhi-NCR, IndiaRetailers will be able to connect with 200+ leading exhibiting brands including organic raw & processed products, bio inputs, natural herbs,
Whirlpool of India launches Ice Magic Pro Glass Door Refrigerator Range for evolving Indian homes
The new range of single-door refrigerators is one-of-its-kind design, inspired by the rich cultural heritage of India. NEW DELHI, July 18, 2024 /PRNewswire/ — Whirlpool of India, a subsidiary of Whirlpool Corporation, has launched a new range of single-door refrigerators- Ice Magic Pro Glass D
LG ACCELERATES SMART FACTORY SOLUTIONS BUSINESS INTEGRATING AI WITH 66-YEAR MANUFACTURING EXPERTISE
Company to Leverage Lighthouse Factory Expertise to Develop Future-Oriented Business Models SEOUL, South Korea, July 18, 2024 /PRNewswire/ — LG Electronics (LG) is advancing its smart factory solutions business by integrating artificial intelligence (AI) and digital transformation (DX) with
BSI receives ISO 37001 certification from Speeki Europe
PARIS, July 18, 2024 /PRNewswire/ — Speeki Europe, a leading certification body specialising in ethical and compliance certifications, has certified the British Standards Institution (BSI) for ISO 37001. ISO 37001 stands out as a globally recognised standard. It guides organisations in establi
Renalys Pharma announces first patient dosed in registrational Phase III clinical trial of sparsentan for IgA nephropathy in Japan
TOKYO, July 18, 2024 /PRNewswire/ — Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; “Renalys Pharma”) announced today that the first person was dosed in its registrational Phase III clinical trial of sparsentan for the treatment of IgA nephropathy in Japan. In April this year
Essity: Interim Report, Quarter 2, 2024
STOCKHOLM, July 18, 2024 /PRNewswire/ — Quarter 2, 2024 – Strong earnings and good underlying growth Net sales decreased 1.2% to SEK 36,617m (37,078)Organic growth amounted to -0.9%, of which volume accounted for 0.4% and price/mix -1.3%. Excluding restructuring and exited contracts, v
HUSQVARNA GROUP: INTERIM REPORT JANUARY – JUNE 2024
STOCKHOLM, July 18, 2024 /PRNewswire/ — Solid cash flow in a quarter affected by weak market conditions Second quarter 2024 Net sales decreased by 9% to SEK 15,430m (16,976). Changes in exchange rates impacted with -1%.Planned exits of low-margin petrol-powered business impacted with -2%. Orga
MicuRx Presents Innovative Antibiotic Research Results at the 7th World Bronchiectasis Conference
MicuRx showcased the latest research progress on their pipeline products, MRX-5 and MRX-8, at the 7th World Bronchiectasis ConferenceThree significant study results further support the potential of MRX-5 and MRX-8 in treating Nontuberculous Mycobacteria (NTM) lung disease and Pseudomonas aeruginosa
GameFi + DePIN: Japanese Web3 Organization Rona Redefines Next-Generation Consoles
“We are a production tool, capable of creating economic value for players.”— YZ, Co-Founder of Rona TOKYO, July 18, 2024 /PRNewswire/ — When GameFi meets DePIN, a revolution in gaming experience is about to unfold. How can we provide users with an ecosystem that not only offers g
